secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viveon Health Acquisition Corp. (—)
CIK:        0001823857
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001493152-24-001508
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Viveon Health restates 2022 financials; consulting fee accrual errors
---------------------------------------------------------------------

- Audit committee determined 2022 annual (10-K) and quarterly (10-Q) financials not reliable due to consulting fee accrual errors.
- Error under-accrued fees and omitted contingent fee disclosures for an October 2021 agreement with an investor relations firm.
- Material weakness in internal controls over accounts payable/accrued expenses and a new weakness in evaluating contractual arrangements.
- Company will file an amended 2022 10-K to restate all affected periods (Q1-Q4 2022).
- This expands prior restatement disclosure (Nov 2023) to include all quarterly periods in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823857/000149315224001508/0001493152-24-001508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823857/000149315224001508/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer